MGIM
TNDM icon

M&G Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

M&G Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,822
Closed -$756 – 468
2022
Q2 		$756 Buy
12,822
+667
+5% +$54.8K ﹤0.01% 371
2022
Q1 		$1.41K Hold
12,155
– – ﹤0.01% 339
2021
Q4 		$1.83K Buy
+12,155
New +$1.64M ﹤0.01% 298

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

M&G Investment Management's TNDM Position: Q3 2022 in Review

M&G Investment Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 12,822 shares — an estimated $756 sold.

M&G Investment Management first reported a position in TNDM in Q4 2021 and held it in 3 quarters. The position peaked at $1.83K in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • M&G Investment Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • M&G Investment Management sold 12,822 Tandem Diabetes Care shares in Q3 2022, an estimated $756.
  • M&G Investment Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 3 quarters.
  • M&G Investment Management's Tandem Diabetes Care position peaked at $1.83K in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on M&G Investment Management's 13F filing for Q3 2022, filed 1 Nov 2022.